Brokerages expect HB Fuller Co (NYSE:FUL) to post sales of $745.95 million for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for HB Fuller’s earnings. The highest sales estimate is $761.60 million and the lowest is $734.00 million. HB Fuller posted sales of $768.43 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 2.9%. The business is scheduled to issue its next quarterly earnings report on Wednesday, January 15th.
According to Zacks, analysts expect that HB Fuller will report full-year sales of $2.90 billion for the current financial year, with estimates ranging from $2.89 billion to $2.92 billion. For the next financial year, analysts expect that the company will report sales of $2.97 billion, with estimates ranging from $2.91 billion to $3.07 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that that provide coverage for HB Fuller.
HB Fuller (NYSE:FUL) last announced its earnings results on Wednesday, September 25th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.04). HB Fuller had a return on equity of 13.20% and a net margin of 4.78%. The business had revenue of $725.38 million for the quarter, compared to analysts’ expectations of $749.18 million. During the same quarter last year, the business posted $0.86 earnings per share. The business’s revenue was down 5.8% on a year-over-year basis.
In other HB Fuller news, VP Robert J. Martsching sold 1,700 shares of the company’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $49.29, for a total value of $83,793.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Paula M. Cooney sold 3,647 shares of the company’s stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $46.47, for a total transaction of $169,476.09. Following the completion of the sale, the vice president now owns 14,057 shares in the company, valued at approximately $653,228.79. The disclosure for this sale can be found here. Insiders sold a total of 112,632 shares of company stock valued at $5,627,484 over the last quarter. 3.46% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently made changes to their positions in the business. JS Capital Management LLC purchased a new stake in shares of HB Fuller during the third quarter valued at approximately $413,000. Barclays PLC grew its holdings in shares of HB Fuller by 38.7% during the third quarter. Barclays PLC now owns 108,686 shares of the specialty chemicals company’s stock valued at $5,061,000 after buying an additional 30,347 shares during the last quarter. California State Teachers Retirement System grew its holdings in shares of HB Fuller by 1.2% during the third quarter. California State Teachers Retirement System now owns 79,369 shares of the specialty chemicals company’s stock valued at $3,695,000 after buying an additional 948 shares during the last quarter. State Street Corp grew its holdings in shares of HB Fuller by 2.0% during the third quarter. State Street Corp now owns 4,302,290 shares of the specialty chemicals company’s stock valued at $200,315,000 after buying an additional 83,223 shares during the last quarter. Finally, Mason Street Advisors LLC grew its holdings in shares of HB Fuller by 1.8% during the third quarter. Mason Street Advisors LLC now owns 17,289 shares of the specialty chemicals company’s stock valued at $805,000 after buying an additional 303 shares during the last quarter. Institutional investors and hedge funds own 98.42% of the company’s stock.
Shares of HB Fuller stock traded down $0.36 during trading on Wednesday, reaching $49.52. The stock had a trading volume of 187,364 shares, compared to its average volume of 357,518. The company has a market capitalization of $2.54 billion, a price-to-earnings ratio of 16.51, a P/E/G ratio of 1.61 and a beta of 1.57. The stock has a fifty day moving average price of $49.39 and a two-hundred day moving average price of $46.04. HB Fuller has a 52 week low of $39.22 and a 52 week high of $52.18. The company has a current ratio of 2.36, a quick ratio of 1.55 and a debt-to-equity ratio of 1.77.
HB Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.
Featured Article: Call Option
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.